no abnormal phenotype detected_Brca2<tm2Mak>/Brca2<tm2Mak>

http://metadb.riken.jp/0002169I129P2OlaHsdC57BL6Brca2tm2MakBrca2tm2MakBrca2tm2Mak

no abnormal phenotype detected_Brca2<tm2Mak>/Brca2<tm2Mak>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• breast cancer 2, early onset
  http://metadb.riken.jp/db/mgi_rdf/MGI:109337

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Brca2<tm2Mak>/Brca2<tm2Mak>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Brca2<tm2Mak>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• no abnormal phenotype detected
  http://purl.obolibrary.org/obo/MP_0002169

文献

http://purl.org/net/cito/citesAsAuthority

• Alison M Y. Cheung, et.al., Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis., Cancer research, 2002, 62
  http://rdf.ncbi.nlm.nih.gov/pubmed/12414647